1. Blanke C, Joensuu H, Demetri G, et al (2004) Long-term follow up of advanced gastrointestinal stromal tumor (GIST) patients treated with imatinib mesylate. ASCO gastrointestinal cancers symposium. Abstr 2
2. DeMatteo RP, Antonescu CR, Chadaram V, et al (2005) Adjuvant imatinib mesylate in patients with primary high risk gastrointestinal stromal tumor (GIST) following complete resection: safety results from the U.S. intergroup phase II trial ACOSOG Z9000. ASCO annual meeting. Abstr 9009
3. Demetri GD, von Mehren M, Blanke CD, et al (2002) Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 347:472–480
4. Demetri GD, van Oosterom AT, Blackstein F, et al (2005) Phase 3, multicenter, randomised, double-blind, placebo-controlled trial of SU11248 in patients (pts) following failure of imatinib for metastatic GIST. ASCO annual meeting. Abstr 4000
5. Golden T, Stout AP (1941) Smooth muscle tumours of the gastrointestinal tract and retroperitoneal tissues. Surg Gynecol Obstet 73:784–790